JPS646179B2 - - Google Patents
Info
- Publication number
- JPS646179B2 JPS646179B2 JP2384481A JP2384481A JPS646179B2 JP S646179 B2 JPS646179 B2 JP S646179B2 JP 2384481 A JP2384481 A JP 2384481A JP 2384481 A JP2384481 A JP 2384481A JP S646179 B2 JPS646179 B2 JP S646179B2
- Authority
- JP
- Japan
- Prior art keywords
- solvent
- multiplet
- ester
- singlet
- benzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002904 solvent Substances 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 6
- 229930004069 diterpene Natural products 0.000 claims description 6
- 150000004141 diterpene derivatives Chemical class 0.000 claims description 6
- 241001448862 Croton Species 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 150000002148 esters Chemical class 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 10
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000000862 absorption spectrum Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 6
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- 241001529550 Croton sublyratus Species 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- -1 alkyl ketones Chemical class 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000002467 anti-pepsin effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NNOHXABAQAGKRZ-UHFFFAOYSA-N 3,5-dinitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC(C(Cl)=O)=CC([N+]([O-])=O)=C1 NNOHXABAQAGKRZ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000711025 Chrozophora oblongifolia Species 0.000 description 1
- 241000628884 Croton columnaris Species 0.000 description 1
- 241001648611 Croton hutchinsonianus Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- GPWDPLKISXZVIE-UHFFFAOYSA-N cyclo[18]carbon Chemical compound C1#CC#CC#CC#CC#CC#CC#CC#CC#C1 GPWDPLKISXZVIE-UHFFFAOYSA-N 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明はジテルペンアルコールの製法に関し、
さらに詳しくはクロトン属植物から、
式
で表わされる(E,Z,E)―7―ヒドロキシメ
チル―3,11,15―トリメチル―2,6,10,14
―ヘキサデカテトラエン―1―オールを分離採集
する方法に関するものである。式()を有する
化合物は特開昭52―70010号に記載されており、
抗消化性潰瘍作用を有する物質である。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing diterpene alcohol,
More specifically, from plants of the genus Croton, the formula (E, Z, E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14
This invention relates to a method for separating and collecting -hexadecatetraen-1-ol. The compound having the formula () is described in JP-A-52-70010,
It is a substance that has anti-peptic ulcer effects.
特開昭52―70010号によると前記式()を有
するジテルペンアルコールの製法はクロトン属植
物、特にタイ国産生薬プラウ―ノイ(Plau―noi
(Croton sublyratus Kurz又はCroton
Columnaris Airy shaw別名Croton joufra
Roxb.)〕、プラウ―ヤイ(Plau―yai(Croton
oblongifolius Roxb.)〕及びプラウ―ルア〔Plau
―luat(Croton Hutchinsonianus Hosseus)〕中
に含まれる化合物()を溶剤で抽出し、抽出液
より通常の植物中性成分分離法またはこれとカラ
ムクロマトグラフイーを併用した方法、或いは誘
導体として結晶化することによつて単離し、その
結晶性エステル誘導体を加水分解する方法により
該目的物を分離している。 According to JP-A-52-70010, the method for producing the diterpene alcohol having the above formula (
(Croton sublyratus Kurz or Croton
Columnaris Airy shaw aka Croton joufra
Roxb.)], Plau-yai (Croton
oblongifolius Roxb.) and Plau
- Compounds contained in luat (Croton Hutchinsonianus Hosseus) are extracted with a solvent, and the extract is crystallized using a conventional plant neutral component separation method, a method that combines this with column chromatography, or a derivative. The desired product is isolated by a method of isolating the crystalline ester derivative and hydrolyzing the crystalline ester derivative.
本発明者らはその収量の向上を目指して鋭意検
討を重ね、抽出液中に、
式
(式中、R1およびR2はその一方が脂肪族アシ
ル基を示し、他方は水素原子を示すか或いは共に
脂肪族アシル基を示す。)
を有するエステル体の存在することを見出し、さ
らに該エステル体の構造研究を行い、エステル体
を構成する脂肪酸を解明した後、該エステル体を
加水分解することにより、目的化合物()を収
率よく分離しうることを見出して本発明を完成す
るに至つた。 The present inventors have made extensive studies with the aim of improving the yield, and have found that the extract contains the formula (In the formula, one of R 1 and R 2 represents an aliphatic acyl group, and the other represents a hydrogen atom, or both represent an aliphatic acyl group.) After conducting structural research on the ester and elucidating the fatty acids that make up the ester, it was discovered that the target compound () could be separated in good yield by hydrolyzing the ester, thereby completing the present invention. I've reached it.
本発明において抽出に使用される溶剤として
は、水又は通常の植物成分の抽出に使用される有
機溶剤例えばメタノール、エタノール、イソプロ
パノールのようなアルコール類、エチルエーテ
ル、イソプロピルエーテルのようなエーテル類、
ジクロルメタン、ジクロルエタン、クロロホルム
のようなハロゲン化炭化水素類、酢酸メチル、酢
酸エチルのような酢酸エステル類、アセトン、メ
チルエチルケトンのような低級アルキルケトン類
又はベンゼン、トルエンのような芳香族炭化水素
類が特に限定なく使用し得る。抽出液中のエステ
ル体()を形成する脂肪酸としては、カプリン
酸、パルミチン酸、ステアリン酸、オレイン酸、
リノール酸、リノレン酸などがモノエステルまた
はジエステルとして含まれる。これらのエステル
体を加水分解するため、抽出液に重曹水のような
重炭酸アルカリ水溶液、炭酸ナトリウム水溶液、
炭酸カリウム水溶液のような炭酸アルカリ水溶液
又は水酸化ナトリウム水溶液、水酸化カリウム水
溶液のような水酸化アルカリ水溶液を加えて処理
するか、或いは抽出に際して有機溶剤にこれらの
塩基水溶液を加えて行つてもよい。 Solvents used for extraction in the present invention include water or organic solvents commonly used for extracting plant components, such as alcohols such as methanol, ethanol and isopropanol, ethers such as ethyl ether and isopropyl ether,
Halogenated hydrocarbons such as dichloromethane, dichloroethane, and chloroform, acetate esters such as methyl acetate and ethyl acetate, lower alkyl ketones such as acetone and methyl ethyl ketone, and aromatic hydrocarbons such as benzene and toluene are particularly preferred. May be used without limitation. The fatty acids that form esters () in the extract include capric acid, palmitic acid, stearic acid, oleic acid,
Linoleic acid, linolenic acid, etc. are included as monoesters or diesters. In order to hydrolyze these esters, an aqueous alkali bicarbonate solution such as aqueous sodium bicarbonate solution, an aqueous sodium carbonate solution,
The treatment may be carried out by adding an aqueous alkali carbonate solution such as an aqueous potassium carbonate solution, an aqueous alkali hydroxide solution such as an aqueous sodium hydroxide solution or an aqueous potassium hydroxide solution, or an aqueous base solution of these bases may be added to an organic solvent during extraction. .
以上の塩基性条件下における加水分解及び溶剤
による抽出工程における反応温度は特に限定はな
いが、通常は加熱還流下に行なうのが好適であ
る。 The reaction temperature in the above-mentioned hydrolysis and solvent extraction steps under basic conditions is not particularly limited, but it is usually preferable to carry out the reaction under heating and reflux.
この抽出液より前記有効成分を含む分画を得る
には通常の植物中性成分採取の方法によつて行な
われる。更に前記構造式()を有する化合物を
単離するには通常の中性成分分離法によつて行な
われるが、カラムクロマトグラフイーを併用する
か、或いは誘導体として結晶化することによつて
単離するのが有利である。 A fraction containing the above-mentioned active ingredients can be obtained from this extract by a conventional method for collecting neutral components of plants. Furthermore, the compound having the above structural formula () can be isolated by a normal neutral component separation method, but it can also be isolated by using column chromatography in combination or by crystallizing it as a derivative. It is advantageous to do so.
即ち、例えば前記抽出物より炭化水素類を除く
ため抽出液または濃縮物をn―ヘキサンのような
炭化水素で洗い、更にベンゼンまたはエーテルの
ような水不混和性溶剤に溶かした後、水洗して有
機溶剤層を無水硫酸ナトリウムのような乾燥剤で
乾燥し、溶液より溶剤を留去すると、抗消化性潰
瘍作用を有する有機溶剤可溶の中性物質分画を得
ることができる。 That is, for example, in order to remove hydrocarbons from the extract, the extract or concentrate is washed with a hydrocarbon such as n-hexane, further dissolved in a water-immiscible solvent such as benzene or ether, and then washed with water. By drying the organic solvent layer with a drying agent such as anhydrous sodium sulfate and distilling off the solvent from the solution, it is possible to obtain a neutral substance fraction soluble in the organic solvent and having an anti-peptic ulcer effect.
更に目的の有効成分を単離するには、シリカゲ
ル、アルミナ、珪酸等の充填剤を使用し、展開溶
剤としてベンゼン、エチルエーテル、酢酸エチ
ル、クロロホルム、アセトン、アルコール等の有
機溶剤の一種または二種以上の混合溶剤あるいは
上記溶剤と石油系溶剤との混合溶剤を使用してカ
ラムクロマトグラフイーを行なう。溶出液より溶
剤を留去すると目的の化合物が得られるが、必要
ならば常法例えば誘導体の生成または減圧蒸留に
よつて更に精製することができる。即ち植物抽出
物より得られた中性成分を、通常アルコール化合
物に使用される結晶性誘導体合成試薬、例えば
3,5―ジニトロベンゾイルクロリド、無水フタ
ル酸、フエニルイソシアネート等と処理すること
によつて結晶性誘導体として単離した後、これを
加水分解することによつて目的化合物を単離する
ことができる。 To further isolate the desired active ingredient, fillers such as silica gel, alumina, and silicic acid are used, and one or two organic solvents such as benzene, ethyl ether, ethyl acetate, chloroform, acetone, and alcohol are used as developing solvents. Column chromatography is performed using the above mixed solvent or a mixed solvent of the above solvent and a petroleum solvent. The target compound is obtained by distilling off the solvent from the eluate, and if necessary, it can be further purified by conventional methods such as formation of derivatives or distillation under reduced pressure. That is, by treating neutral components obtained from plant extracts with crystalline derivative synthesis reagents commonly used for alcohol compounds, such as 3,5-dinitrobenzoyl chloride, phthalic anhydride, phenyl isocyanate, etc. After isolation as a crystalline derivative, the target compound can be isolated by hydrolyzing this.
次に実施例をあげて本発明の方法を更に具体的
に説明するが本発明の方法はこれに限定されるも
のではない。 Next, the method of the present invention will be explained in more detail with reference to Examples, but the method of the present invention is not limited thereto.
実施例 1
粉砕したタイ国産生薬プラウ―ノイ2.8Kgをメ
タノール10で3回加熱還流下に抽出した。抽出
液を5まで濃縮しこれに10%水酸化ナトリウム
水溶液1を加え加熱還流下0.5時間加水分解し
た後溶剤を留去し、残渣をエチルエーテルで抽出
した。エチルエーテル溶液を水洗し、無水硫酸ナ
トリウムで乾燥後溶剤を留去した。残留物を500
gのシリカゲルを使用したカラムに吸着させ、最
初10%酢酸エチル含有ベンゼンで溶出した後、30
%酢酸エチル含有ベンゼンで溶出した。30%酢酸
エチル含有ベンゼンの溶出分画中有効成分を含有
する部分の溶剤を留去すると無色粘稠油として目
的のジテルペンアルコール()が2.04g得られ
た。Example 1 2.8 kg of pulverized Thai medicine Prawn Noi was extracted three times with 10 methanol under heating and reflux. The extract was concentrated to a concentration of 5%, 10% aqueous sodium hydroxide solution was added thereto, and the mixture was hydrolyzed under heating under reflux for 0.5 hours.The solvent was distilled off, and the residue was extracted with ethyl ether. The ethyl ether solution was washed with water, dried over anhydrous sodium sulfate, and then the solvent was distilled off. 500 residue
It was adsorbed onto a column using 10 g of silica gel, first eluted with benzene containing 10% ethyl acetate, and then 30 g of silica gel was used.
% ethyl acetate in benzene. When the solvent in the portion containing the active ingredient in the benzene elution fraction containing 30% ethyl acetate was distilled off, 2.04 g of the desired diterpene alcohol (2) was obtained as a colorless viscous oil.
実施例 2
粉砕したタイ国生薬プラウ―ノイ1Kgを40%水
酸化ナトリウム水溶液150ml含有メタノール3
で加熱還流下に抽出した。抽出液の溶剤を留去後
残留物をエチルエーテルで抽出し、エチルエーテ
ル溶液を実施例1と同様に処理すると目的のジテ
ルペンアルコール()0.77gが得られた。Example 2 1 kg of crushed Thai herbal medicine Pulau Noi was added to methanol 3 containing 150 ml of a 40% sodium hydroxide aqueous solution.
The mixture was extracted under heating under reflux. After distilling off the solvent of the extract, the residue was extracted with ethyl ether, and the ethyl ether solution was treated in the same manner as in Example 1 to obtain 0.77 g of the desired diterpene alcohol ().
実施例 3
粉砕したCroton sublyratus Kurzの葉500gを
40%水酸化ナトリウム水溶液200ml含有メタノー
ル2.5で加熱還流下に1時間抽出した。抽出液
を実施例2と同様に処理すると目的のジテルペン
アルコール()3.0gが得られた。Example 3 500g of crushed Croton sublyratus Kurz leaves
The mixture was extracted with 2.5 methanol containing 200 ml of 40% aqueous sodium hydroxide solution under heating under reflux for 1 hour. The extract was treated in the same manner as in Example 2 to obtain 3.0 g of the desired diterpene alcohol ().
参考例 1
粉砕したCroton sublyratus Kurzの葉5Kgを
塩化メチレン20で加熱還流下3回抽出した。抽
出液を合して溶剤を留去し、残留物を1.5Kgのシ
リカゲルを使用したカラムに吸着させ、ノルマル
―ヘキサンで溶出した。溶出液の一部を採取し、
溶剤を留去して残留物を水酸化ナトリウム水溶液
含有メタノールで加水分解し、化合物()を含
有するか否かを薄層クロマトグラフイー(シリカ
ゲル使用、展開溶剤ベンゼン―酢酸エチル1:
1)で調べた。このようにして化合物()のエ
ステル体を含有する分画を集め溶剤を留去した。
残留物を分離用シリカゲル薄層クロマトグラフイ
ーに吸着させ、ベンゼンで展開した。前記と同様
にして化合物()のエステル体を含有する部分
を調べて分画し、各分画から次のエステル体を単
離した。Reference Example 1 5 kg of crushed Croton sublyratus Kurz leaves were extracted three times with 20 methylene chloride under heating and reflux. The extracts were combined and the solvent was distilled off, and the residue was adsorbed on a column using 1.5 kg of silica gel, and eluted with n-hexane. Collect a portion of the eluate,
The solvent was distilled off, the residue was hydrolyzed with methanol containing an aqueous sodium hydroxide solution, and the presence or absence of compound () was determined by thin layer chromatography (using silica gel, developing solvent benzene-ethyl acetate 1:
1) was investigated. In this way, fractions containing the ester form of compound () were collected and the solvent was distilled off.
The residue was adsorbed onto preparative silica gel thin layer chromatography and developed with benzene. In the same manner as above, the portion containing the ester form of compound () was examined and fractionated, and the following ester forms were isolated from each fraction.
エステル A
Rf:0.62(シリカゲル薄層クロマトグラフイー、
展開溶剤ベンゼン)。Ester A R f : 0.62 (silica gel thin layer chromatography,
(developing solvent benzene).
赤外線吸収スペクトル νcm-1(液膜):2925,
2850,1740,1460,1380,1240,1170,
1120,1030。 Infrared absorption spectrum νcm -1 (liquid film): 2925,
2850, 1740, 1460, 1380, 1240, 1170,
1120, 1030.
核磁気共鳴スペクトル δppm(CCl4):5.4―
4.8(多重線)、4.46(一重線)、4.41(二重
線)、2.5―1.8(多重線)、1.8―1.5(多重
線)、1.25(一重線)、1.85(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.4―
4.8 (multiplet), 4.46 (singlet), 4.41 (doublet), 2.5-1.8 (multiplet), 1.8-1.5 (multiplet), 1.25 (singlet), 1.85 (multiplet).
エステル B Rf:0.45(同上、展開溶剤ベンゼン)。Ester B R f :0.45 (same as above, developing solvent benzene).
赤外線吸収スペクトル νcm-1(液膜):2920,
2850,1740,1440,1375,1230,1170,
1110,1025。 Infrared absorption spectrum νcm -1 (liquid film): 2920,
2850, 1740, 1440, 1375, 1230, 1170,
1110, 1025.
核磁気共鳴スペクトル δppm(CCl4):5.4―
4.7(多重線)、4.46(一重線)、4.40(二重
線)、2.4―1.9(多重線)、1.9―1.5(多重
線)、1.27(一重線)、1.86(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.4―
4.7 (multiplet), 4.46 (singlet), 4.40 (doublet), 2.4-1.9 (multiplet), 1.9-1.5 (multiplet), 1.27 (singlet), 1.86 (multiplet).
エステル C
Rf:0.70(同上、展開溶剤ベンゼン―酢酸エチ
ル20:1)。Ester C R f :0.70 (same as above, developing solvent benzene-ethyl acetate 20:1).
赤外線吸収スペクトル νcm-1(液膜):2925,
2850,1740,1450,1380,1235,1170,
1125,1080,1030。 Infrared absorption spectrum νcm -1 (liquid film): 2925,
2850, 1740, 1450, 1380, 1235, 1170,
1125, 1080, 1030.
核磁気共鳴スペクトル δppm(CCl4):5.4―
4.8(多重線)、4.47(一重線)、4.41(二重
線)、2.5―1.85(多重線)、1.85―1.5(多重
線)、1.26(一重線)、1.88(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.4―
4.8 (multiplet), 4.47 (singlet), 4.41 (doublet), 2.5-1.85 (multiplet), 1.85-1.5 (multiplet), 1.26 (singlet), 1.88 (multiplet).
エステル D
Rf:0.91(同上、展開溶剤ベンゼン―酢酸エチ
ル20:1)。Ester D R f :0.91 (same as above, developing solvent benzene-ethyl acetate 20:1).
赤外線吸収スペクトル νcm-1(液膜):2930,
2860,1740,1670,1460,1380,1240,
1180,1120,970。 Infrared absorption spectrum νcm -1 (liquid film): 2930,
2860, 1740, 1670, 1460, 1380, 1240,
1180, 1120, 970.
核磁気共鳴スペクトル δppm(CCl4):5.4―
4.7(多重線)、4.46(一重線)、4.41(二重
線)、2.5―1.8(多重線)、1.8―1.5(多重
線)、1.27(一重線)、1.88(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.4―
4.7 (multiplet), 4.46 (singlet), 4.41 (doublet), 2.5-1.8 (multiplet), 1.8-1.5 (multiplet), 1.27 (singlet), 1.88 (multiplet).
エステル E
Rf:0.91(同上、展開溶剤ベンゼン―酢酸エチ
ル5:1)。Ester E R f :0.91 (same as above, developing solvent benzene-ethyl acetate 5:1).
赤外線吸収スペクトル νcm-1(液膜):2920,
2850,1735,1685,1450,1380,1230,
1170,1025。 Infrared absorption spectrum νcm -1 (liquid film): 2920,
2850, 1735, 1685, 1450, 1380, 1230,
1170, 1025.
核磁気共鳴スペクトル δppm(CCl4):5.4―
4.8(多重線)、4.45(一重線)、4.39(二重
線)、2.4―1.8(多重線)、1.8―1.5(多重
線)、1.25(一重線)、1.88(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.4―
4.8 (multiplet), 4.45 (singlet), 4.39 (doublet), 2.4-1.8 (multiplet), 1.8-1.5 (multiplet), 1.25 (singlet), 1.88 (multiplet).
エステル F
Rf:0.83(同上、展開溶剤ベンゼン―酢酸エチ
ル2:1)。Ester F R f : 0.83 (same as above, developing solvent benzene-ethyl acetate 2:1).
赤外線吸収スペクトル νcm-1(液膜):3370,
2920,2850,1735,1455,1375,1235,
1170,1110,1005。 Infrared absorption spectrum νcm -1 (liquid film): 3370,
2920, 2850, 1735, 1455, 1375, 1235,
1170, 1110, 1005.
核磁気共鳴スペクトル δppm(CCl4):5.6―
4.7(多重線)、4.47(一重線)、3.98(二重
線)、2.4―1.8(多重線)、1.8―1.5(多重
線)、1.25(一重線)、0.91(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.6―
4.7 (multiplet), 4.47 (singlet), 3.98 (doublet), 2.4-1.8 (multiplet), 1.8-1.5 (multiplet), 1.25 (singlet), 0.91 (multiplet).
エステル G
Rf:0.80(同上、展開溶剤ベンゼン―酢酸エチ
ル1:1)。Ester G R f :0.80 (same as above, developing solvent benzene-ethyl acetate 1:1).
赤外線吸収スペクトル νcm-1(液膜):3360,
2920,2850,1735,1715,1675,1635,
1435,1375,1235,1170,1110,1005,
970。 Infrared absorption spectrum νcm -1 (liquid film): 3360,
2920, 2850, 1735, 1715, 1675, 1635,
1435, 1375, 1235, 1170, 1110, 1005,
970.
核磁気共鳴スペクトル δppm(CCl4):5.6―
4.7(多重線)、4.45(一重線)、3.96(二重
線)、2.4―1.9(多重線)、1.9―1.4(多重
線)、1.27(一重線)、0.93(多重線)。 Nuclear magnetic resonance spectrum δppm (CCl 4 ): 5.6―
4.7 (multiplet), 4.45 (singlet), 3.96 (doublet), 2.4-1.9 (multiplet), 1.9-1.4 (multiplet), 1.27 (singlet), 0.93 (multiplet).
これらエステル体のうち核磁気共鳴スペクトル
の結果よりエステルA,B,C,DおよびEは化
合物()のジエステル体、エステルFおよびG
は炭素18位のみのモノエステル体であることが判
明した。 Among these esters, the results of nuclear magnetic resonance spectroscopy show that esters A, B, C, D and E are diesters of compound (), and esters F and G
was found to be a monoester containing only carbon 18.
つぎにエステルA,B,C,D,E,Fおよび
Gの各一部を水酸化ナトリウム水溶液含有メタノ
ール中で加水分解した。溶剤を留去後残留物に希
塩酸を加え、エチルエーテルで抽出した。エチル
エーテル層を水洗し、無水硫酸ナトリウムで乾燥
後溶剤を留去し、乾燥した。得られたものをエチ
ルエーテルに溶解し、ジアゾメタンのエーテル溶
液を加えて室温に放置した。この溶液をガスクロ
マトグラフイー(充填剤:10%カーボワツクス
20M、気化部、検出部温度200度、カラム温度80
度、試料導入2分後より毎分10度の割合で250度
まで昇温した)に付し、標準品脂肪酸メチルエス
テルと保持時間を比較することにより含有される
脂肪酸を決定した。その結果エステルA〜Gは、
それぞれつぎのような脂肪酸と化合物()から
成るエステル体であることが明らかとなつた。 Next, a portion of each of esters A, B, C, D, E, F and G was hydrolyzed in methanol containing an aqueous sodium hydroxide solution. After evaporating the solvent, dilute hydrochloric acid was added to the residue, and the mixture was extracted with ethyl ether. The ethyl ether layer was washed with water, dried over anhydrous sodium sulfate, and then the solvent was distilled off and dried. The obtained product was dissolved in ethyl ether, an ether solution of diazomethane was added, and the mixture was left at room temperature. This solution was subjected to gas chromatography (filling agent: 10% carbo wax).
20M, vaporization section, detection section temperature 200 degrees, column temperature 80 degrees
2 minutes after introduction of the sample, the temperature was increased to 250 degrees at a rate of 10 degrees per minute), and the fatty acids contained were determined by comparing the retention time with standard fatty acid methyl ester. As a result, esters A to G are
It was revealed that each of these is an ester consisting of the following fatty acids and compounds ().
エステルA:カプリン酸とパルミチン酸 エステルB:カプリン酸とオレイン酸 エステルC:パルミチン酸とオレイン酸 エステルD:オレイン酸とパルミチン酸 エステルE:リノール酸とリノレン酸 エステルF:ステアリン酸 エステルG:オレイン酸Ester A: Capric acid and palmitic acid Ester B: Capric acid and oleic acid Ester C: palmitic acid and oleic acid Ester D: Oleic acid and palmitic acid Ester E: Linoleic acid and linolenic acid Ester F: stearic acid Ester G: Oleic acid
Claims (1)
得られた抽出物を、塩基性条件下に加水分解した
後、溶剤で抽出するか、クロトン属植物を直接塩
基性条件下に加水分解すると同時に溶剤で抽出す
ることを特徴とする、 式 を有するジテルペンアルコールの製法。[Claims] 1. An extract obtained by extracting a Croton genus plant with a solvent is hydrolyzed under basic conditions and then extracted with a solvent, or a Croton genus plant is directly subjected to basic conditions. A formula characterized by hydrolysis and simultaneous extraction with a solvent. A method for producing a diterpene alcohol having
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2384481A JPS57139029A (en) | 1981-02-20 | 1981-02-20 | Preparation of diterpene alcohol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2384481A JPS57139029A (en) | 1981-02-20 | 1981-02-20 | Preparation of diterpene alcohol |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57139029A JPS57139029A (en) | 1982-08-27 |
JPS646179B2 true JPS646179B2 (en) | 1989-02-02 |
Family
ID=12121706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2384481A Granted JPS57139029A (en) | 1981-02-20 | 1981-02-20 | Preparation of diterpene alcohol |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57139029A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2246128B (en) * | 1990-06-14 | 1994-03-09 | Rackham Anthony Charles | Process for extraction and purification of plaunotol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011017B2 (en) * | 1975-12-05 | 1985-03-22 | 三共株式会社 | Production method of diterpene alcohol |
-
1981
- 1981-02-20 JP JP2384481A patent/JPS57139029A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57139029A (en) | 1982-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5459160A (en) | Iridoid derivatives and the use thereof as a drug | |
US5017562A (en) | Crystalline saponin-containing complex | |
Fried et al. | The hypotensive principles of Veratrum viride | |
GB1599863A (en) | Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid | |
Camps et al. | Clerodane diterpenoids from Teucrium and Ajuga plants | |
Engelbrecht et al. | A new sterol from an alcyonarian | |
US3422090A (en) | Process of producing esters from plants of the genus valeriana | |
JPS646179B2 (en) | ||
JPS6011017B2 (en) | Production method of diterpene alcohol | |
US4164584A (en) | Anti-leukemic trichothecene epoxides | |
Clarke et al. | The structure of cassaic acid | |
JP2636896B2 (en) | Phospholipid emulsifier | |
US4147777A (en) | Sericosides and method of use | |
EP0222912A1 (en) | Agent for treating arteriosclerosis | |
JPH0952899A (en) | Leucotriene antagonist | |
Anderson et al. | Nonpolar pentacyclic triterpenes of the medicinal fern Polypodium subpetiolatum | |
CS223879B2 (en) | Method of gaining natural terpenes with antipsoriatic effect | |
US2480991A (en) | Method of producing penicillin preparations | |
US5264638A (en) | Process for extraction and purification of plaunotol | |
FR2510577A1 (en) | ORGANIC NITROGEN COMPOUNDS EXTRACTED FROM PLANTS AND THEIR DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES, IN PARTICULAR AS ANTINEOPLASTIC AGENTS | |
JPS61268648A (en) | Production of oleanolic acid | |
US2312482A (en) | Derivatives of the cyclopentanopolyhydrophenanthrene series | |
JPH0149152B2 (en) | ||
JPH0260680B2 (en) | ||
CA1169433A (en) | Method for preparing an antihypertensive agent comprising 1-0-alkyl-2-acetoyl-sn-glycero-3- phosphocholine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |